EN
抗体药类似物
Research Grade Tixagevimab
All
TD-VK565086_1.jpg
TD-VK565086_2.jpg
  • CatalogTD-VK565086
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsAZD8895,COV2-2196,CAS:2420564-02-7
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Tixagevimab


Catalog No. TD-VK565086
Species reactivity SARS-CoV-2 (2019-nCoV)
Applications Research Grade Biosimilar
Host species Human
Isotype IgG1, kappa
Expression system Mammalian Cells
Clonality Monoclonal
Target Spike glycoprotein, S glycoprotein, E2, Peplomer protein, Spike protein S1, Spike protein S2, Spike protein S2', S, 2
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession P0DTC2
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names AZD8895,COV2-2196,CAS:2420564-02-7
Background Tixagevimab (AZD8895) is a human monoclonal antibody that targets the SARS-CoV-2 receptor binding domain (RBD). It exhibits neutralizing activity against SARS-CoV-2 by binding to the RBD and the S-glycoprotein ectodomain and blocking S-glycoprotein-mediated binding to the receptor.
Note For research use only. Not for use in clinical or therapeutic applications.

 

TD-VK565086_1.jpg
Bioactivity
 
SEC-HPLC detection for Research Grade Tixagevimab.
TD-VK565086_2.jpg
SDS-PAGE
 
SDS-PAGE for Research Grade Tixagevimab.